Found 5 matching trials
A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia PHASE1 This study intends to randomly divide the SAT patients admitted to the ICU ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors NA The purpose of this clinical trial is to evaluate the safety and efficacy o...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training N/A Cross-sectional study, observation made by healthcare professionals of subj...
Show More Learn More & Join Trial
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia PHASE3 The goal of this clinical trial is to demonstrate equivalent efficacy and c...
Show More Status
Active Not Recruiting
Location
Kaluga Regional Clinical Hospital
Learn More & Join Trial
A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia PHASE3 This is a randomized, double-blind, multicenter trial designed to evaluate ...
Show More Location
Multiple Locations
Learn More & Join Trial